核酸感应的Toll-Like受体9/Toll-Like受体7系统是IgA脏病的潜在治疗标

Mingfeng Lee1, Hitoshi Suzuki2, Kei Ogiwara1

  • 1Department of Nephrology, Juntendo University Faculty of Medicine, Tokyo, Japan.

Kidney international
|August 30, 2023
PubMed
概括

收费类受体 (TLR) 7的激活加剧IgA脏病 (IgAN) 通过增加异常糖化IgA. 针对核酸感应TLRs可能为Igan患者提供新的治疗策略.